• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Friday 06/22/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

TumorGenesis Inc

  • 9:37 AM

    MINNEAPOLIS, Feb. 27, 2018 (GLOBE NEWSWIRE) — Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical (NASDAQ:SKLN), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today it has formed a wholly owned subsidiary, TumorGenesis Inc., to develop the next generation or patient derived (“PDx”) tumor models for precision cancer therapy and drug development. The Company formed TumorGenesis Inc. to develop a new, rapid approach to growing tumors in the laboratory, which essentially

    Read more
  • 3:10 PM

    Jan 12, 2016, GTHP OTC Disclosure & News Service – Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today fourth quarter sales revenue for the LuViva® Advanced Cervical Scan was the highest since the launch of the product. LuViva product revenue was approximately $276,000 for the fourth quarter of 2015 versus approximately $183,000 for the same period of 2014, an increase of about 51%. Total sales for

    Read more
  • 4:05 PM

    Dec 03, 2015, GTHP OTC Disclosure & News Service – Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it shipped the first 10,000 LuViva® Advanced Cervical Scan single-patient-use Cervical Guide disposables for the Turkish Ministry of Health (MOH) contract. The $14 million contract calls for 25 LuViva units and 40,000 disposable Cervical Guides before the end of 2015. Four LuViva units and 10,000 Cervical Guides

    Read more
  • 2:27 PM

    Oct 27, 2015 OTC Disclosure & News Service – Guided Therapeutics, Inc., GTHP, OTCQB, (OTCQB:GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it is now negotiating with three groups for rights to sell LuViva in China and other Asian markets. The framework of the negotiations is an upfront licensing fee with ongoing royalties in exchange for exclusive right to market and sell LuViva and its single-patient-use disposables. In April,

    Read more
  • 2:11 PM

    Jun 30, 2015 OTC Disclosure & News Service-Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) announced today that it has entered into a securities purchase agreement with certain accredited investors for the private placement of its convertible preferred stock and warrants to purchase shares of its common stock. Gross cash proceeds to the Company are expected to be approximately $4.0 million, prior to the payment of placement agent fees and expenses. In advance of the private placement, the Company negotiated various

    Read more
  • 7:19 PM

    NORCROSS, Ga., Nov 26, 2014 (BUSINESS WIRE) — Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced the pricing of a public offering and the entry into definitive agreements with purchasers for the sale of approximately 16.8 million shares of its common stock, and warrants to purchase shares of its common stock, for gross proceeds to the Company (including non-cash extinguishment of debt) of approximately $3.8 million. The shares and warrants are being offered at a combined price of $0.225 per

    Read more
Public Wire Banner